Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

High blood pressure, also called hypertension, affects over 1.5 billion people around the world. It increases the risk of ...

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

Hypertension affects one in three adults globally and is the leading modifiable risk factor for cardiovascular disease.

Expanded screening using the Vaidya & Carey algorithm significantly improved primary aldosteronism detection in patients with ...

A large number of hypertension patients may unknowingly suffer from primary aldosteronism (PA) — a common but underdiagnosed ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as ...

Primary aldosteronism accounts for up to 30% of all hypertension cases across the globe, but Leung's group previously found that less than 1% of Canadian patients were diagnosed and treated.

For patients who already have a positive result on a screening test for primary aldosteronism (PA), confirmatory testing with the seated saline suppression test (SSST) adds little to the ...

Hi. I was diagnosed with this condition. Adrenal Hyperplasia, both Adrenal Glands over producing Aldosterone. I am on Aldactone 25mg since June 2015 with - Feb 2015 lisinopril 20mg & - 2008 amlodopine ...

Until now, the primary treatment for primary aldosteronism was the surgical removal of the affected adrenal gland. While effective, this procedure required general anesthesia, a hospital stay of ...